The Societal Value of Vaccination in the Age of Covid-19
Bibliographic Data
| ID | 11035908 |
|---|---|
| Authors | David E Bloom (0000-0003-3731-3345, The authors are with the Department of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, MA.), Daniel Cadarette (0000-0003-1853-0651, The authors are with the Department of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, MA.), Maddalena Ferranna (0000-0002-3892-8301, The authors are with the Department of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, MA.) |
| Year | 2021 |
| Volume | 111 |
| Issue | 6 |
| Pages | 1049-1054 |
| Publication date | 2021-06-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | American Journal of Public Health (JOURNAL) |
| Journal identifiers | ISSN: 0090-0036 • E-ISSN: 1541-0048 |
| Publisher | American Public Health Association (PUBLISHER • US) |
| DOI | 10.2105/ajph.2020.306114 |
| PMID | 33856880 |
| OpenAlex | W3154230361 |
| Language | EN |
| Citations received | 3 |
| References cited | 16 |
In recent years, academics and policymakers have increasingly recognized that the full societal value of vaccination encompasses broad health, economic, and social benefits beyond avoided morbidity and mortality due to infection by the targeted pathogen and limited health care costs. Nevertheless, standard economic evaluations of vaccines continue to focus on a relatively narrow set of health-centric benefits, with consequences for vaccination policies and public investments. The COVID-19 pandemic illustrates in stark terms the multiplicity and magnitude of harms that infectious diseases may inflict on society. COVID-19 has overtaxed health systems, disrupted routine immunization programs, forced school and workplace closures, impeded the operation of international supply chains, suppressed aggregate demand, and exacerbated existing social inequities. The obvious nature of the pandemic’s broad effects could conceivably convince more policymakers to identify and account for the full societal impacts of infectious disease when evaluating the potential benefits of vaccination. Such a shift could make a big difference in how we allocate societal resources in the service of population health and in how much we stand to gain from that spending
Coronavirus disease 2019 (COVID-19) · Development economics · Disease · Economic growth · Economics · Environmental health · Health care · Infectious disease (medical specialty) · Pandemic · Political science · Population · Public economics · Public health · Social distance · Vaccination · COVID-19 epidemiological studies · Global Health Care Issues · Immunology · Medicine · Vaccine Coverage and Hesitancy
Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece
The barriers, facilitators and association of vaccine certificates on Covid-19 vaccine uptake
A Social Media‒Based Public Health Campaign Encouraging Covid-19 Vaccination Across the United States
| Unique citing works | 3 |
|---|---|
| Citations per year | 0,75 |
| Citation span | 2022 - 2023 (2) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 3 |